BNP Paribas Asset Management’s Immunocore IMCR Stock Holding History

BNP Paribas Asset Management’s Portfolio IMCR Stock Details IMCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.89M	Sell	90,949 -3,987	-4%	-$118K	﹤0.01%	1039
2026 Q1	$2.86M	Sell	94,936 -968	-1%	-$31.3K	﹤0.01%	991
2025 Q4	$3.33M	Buy	+95,904	New	+$3.39M	﹤0.01%	941
2025 Q3	–	Sell	-129,410	Closed	-$4.06M	–	1965
2025 Q2	$4.06M	Sell	129,410 -31,882	-20%	-$990K	0.01%	607
2025 Q1	$4.79M	Hold	161,292	–	–	0.01%	552
2024 Q4	$4.76M	Sell	161,292 -265,860	-62%	-$8.41M	0.01%	570
2024 Q3	$13.3M	Buy	427,152 +29,689	+7%	+$1.08M	0.03%	387
2024 Q2	$13.5M	Buy	397,463 +55,463	+16%	+$2.83M	0.03%	369
2024 Q1	$22.2M	Buy	342,000 +158,455	+86%	+$10.9M	0.06%	290
2023 Q4	$12.5M	Buy	+183,545	New	+$9.54M	0.03%	385

Other funds holding IMCR

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

VPC

Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

BNP Paribas Asset Management's IMCR Position: Q2 2026 in Review

BNP Paribas Asset Management reduced its Immunocore (IMCR) stake by 4.2% in Q2 2026, selling an estimated $118K and leaving 90,949 shares worth $2.89M. The position accounts for ﹤0.01% of the portfolio, ranked #1039.

BNP Paribas Asset Management first reported a position in IMCR in Q4 2023 and has held it in 10 quarters since. The position peaked at $22.2M in Q1 2024. 136 funds tracked by Wall St. Rank hold IMCR as of Q2 2026.

BNP Paribas Asset Management held 90,949 shares of Immunocore worth $2.89M as of Q2 2026.
BNP Paribas Asset Management sold 3,987 Immunocore shares in Q2 2026, an estimated $118K.
Immunocore made up ﹤0.01% of BNP Paribas Asset Management's portfolio in Q2 2026, its #1039 holding.
BNP Paribas Asset Management first reported a position in Immunocore in Q4 2023 and has held it in 10 quarters since.
BNP Paribas Asset Management's Immunocore position peaked at $22.2M in Q1 2024.
136 funds tracked by Wall St. Rank held Immunocore as of Q2 2026.

Based on BNP Paribas Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.